Cancer Cells Survive Treatment, Seed New Tumors

Uncovering Persister Cell Vulnerabilities

Researchers at the University of California - San Francisco have made a breakthrough in understanding cancer cells that evade treatment. These cells, known as „persisters,”are rare and can regrow tumors, forcing patients into repeated cycles of testing and treatment.

Health news

New Anticancer Vaccine Targets NeuroblastomaUnlocking the Body's Emergency Blood Factory SecretsFish Oil Fails to Halt Alzheimer's DeclineNew National Digital Health Index Revealed

Cancer drugs can shrink fast-growing tumors, but sometimes a few cells survive. The problem is, persister cells are rare - as few as one in a thousand tumor cells - and they're genetically distinct from other tumor cells.

Can Persister Cells be Targeted?

The research team identified vulnerabilities shared by persister cells across different cancer types. By analyzing the genetic profiles of these cells, they discovered that persister cells often have specific characteristics that allow them to evade treatment.

The study's findings suggest that targeting these shared vulnerabilities could lead to more effective cancer treatments. If persister cells can be eliminated, it may be possible to prevent tumor regrowth and reduce the need for repeated treatments.

Frequently Asked Questions

The discovery has significant implications for cancer patients, who may one day benefit from treatments that target persister cells. This could lead to more effective and sustainable cancer therapies.

What are persister cells? Persister cells are a small subset of cancer cells that survive treatment and can regrow tumors. They are genetically distinct from other tumor cells and are thought to be responsible for tumor recurrence. How do persister cells evade treatment? Persister cells have specific characteristics that allow them to survive treatment, but the exact mechanisms are still being studied. Can targeting persister cells improve cancer treatment? Yes, targeting persister cells could lead to more effective and sustainable cancer therapies.